FLUGEN BEGINS ENROLLMENT OF CLINICAL TRIAL OF NOVEL INVESTIGATIONAL INFLUENZA VACCINE AGAINST MULTI-SEASON MISMATCHED STRAINS —Investigational vaccine designed to generate broad and durable immune protection over multiple influenza seasons— —Subjects… read more →
VIRUS PROTECTION | EUROPEAN STUDY PLANNED JUDY NEWMAN jdnewman@madison.com FluGen, a Madison company developing a universal influenza vaccine, is gearing up for a new round of studies on human volunteers… read more →
January 17, 2018 By David Tenenbaum For news media Amid predictions that this year’s flu vaccine will offer limited protection, medical researchers are renewing their focus on a universal flu… read more →
Medical experts are bracing for one of the worst flu seasons in history. The main flu strain for 2017-18 is known as the H3N2 virus, and it is more deadly… read more →
October 18, 2017 09:00 AM Eastern Daylight Time MADISON, Wis.–(BUSINESS WIRE)–FluGen Inc., announced today that it has been awarded a grant of $14.4 million through the DOD’s Congressionally Directed Medical… read more →